Hero Banner

PRESS RELEASES

Date Title and Summary View
Toggle Summary Ultralife Corporation to Report Second Quarter Results on July 25, 2024
NEWARK, N.Y. , July 11, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2024 before the market opens on Thursday, July 25, 2024 . Ultralife’s Management will also host an investor conference call and simultaneous
View HTML
Toggle Summary Ultralife Corporation Added to Russell 2000® Index
NEWARK, N.Y., July 01, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has been added to the Russell 2000® Index and the broad market Russell 3000® Index as part of the 2024 annual reconstitution of the index, effective at the open of the U.S. equity market today, July 1, 2024.
View HTML
Toggle Summary Ultralife Corporation Reports First Quarter Results
NEWARK, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2024 with the following highlights: Sales of $41.9 million representing a 31.4% year-over-year increase, including 54.7% growth in medical market
View HTML
Toggle Summary Ultralife Corporation to Report First Quarter Results on April 25, 2024  
NEWARK, N.Y., April 11, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2024 before the market opens on Thursday, April 25, 2024. Ultralife’s Management will also host an investor conference call and simultaneous
View HTML
Toggle Summary Ultralife Corporation Reports Fourth Quarter Results
NEWARK, N.Y., Feb. 15, 2024 (GLOBE NEWSWIRE) --  Ultralife Corporation (NASDAQ:   ULBI) reported operating results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter Highlights: Sales of $44.5 million representing a 23.4% year-over-year increase Highest medical sales
View HTML
Toggle Summary Ultralife Corporation to Report Fourth Quarter Results on February 15, 2024
NEWARK, N.Y., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ended December 31, 2023 before the market opens on Thursday, February 15, 2024. Ultralife’s Management will also host an investor conference call and
View HTML
Toggle Summary Ultralife Corporation Reports Third Quarter Results
NEWARK, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2023 with the following highlights: Sales of $39.5 million representing an 18.8% year-over-year increase Operating income of $2.1 million versus
View HTML
Toggle Summary Ultralife Corporation to Report Third Quarter Results on October 26, 2023
NEWARK, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2023 before the market opens on Thursday, October 26, 2023. Ultralife’s Management will also host an investor conference call and
View HTML
Toggle Summary Ultralife Corporation Reports Second Quarter Results
NEWARK, N.Y., July 27, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2023 with the following highlights: Sales of $42.7 million representing a 32.9% year-over-year increase Operating income of $3.7 million compared to
View HTML
Toggle Summary Ultralife Corporation to Report Second Quarter Results on July 27, 2023  
NEWARK, N.Y., July 13, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2023 before the market opens on Thursday, July 27, 2023. Ultralife’s Management will also host an investor conference call and simultaneous
View HTML